Medication Exposure Definitions in Perinatal Pharmacoepidemiology: Implications for Pregnancy Studies
Paediatric and Perinatal Epidemiology · 2026
DOI: 10.1111/ppe.70158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Paediatric and Perinatal Epidemiology, 2026. Verfasst von Gabra Nohmie und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medications and Pregnancy Unit of the CHU Sainte-Justine Azrieli Research Center, Montréal, Québec, Canada. Hauptthemen laut MEDLINE: Pharmacoepidemiology, Pregnancy Complications. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Exposure definitions in real‐world pregnancy studies vary across studies, data sources, treatments and outcomes, yet their impact on prevalence estimates remains unexamined.
Objectives
To identify the most used exposure definitions during the 1st trimester and evaluate their impact on prevalence estimates: Methods We reviewed 400 randomly selected articles on medication use during pregnancy to identify exposure definitions. Using Danish health registers (1997–2024) and the Québec Pregnancy Cohort (1998–2015), we analysed chronic, as‐needed, and acute medication use. Prevalence (per 1000) was calculated per definition, including: (1) ≥ 1 or (2) ≥ 2 filled prescriptions during 1st trimester; filled ≥ 1 prescription anytime between the 1st trimester or (3) 30 days, (4) 60 days, (5) 90 days, (6) 6 months before conception; filled a prescription during 1st trimester or before conception, (7) assuming 1 daily defined dose per day or (8) prescribed days overlapping 1st trimester. Trends across cohorts and medications were compared.
Results
We analysed 1,524,075 pregnancies in Denmark and 229,000 in Québec, Canada. The most common exposure definitions identified from the literature were Definition 1 (83%), followed by Definition 3 (13%). Prevalence varied across definitions, with differential impacts depending on medication and type of use. Definition 6 (1st trimester or within the 6 months before conception) yielded the highest prevalence; Definition 2 (≥ 2 fills in 1st trimester) the lowest. Broader time‐windows of exposure increased prevalence, with variation by medication. The prevalence of medication use, whether chronic or acute, showed less variation across definitions than that of as‐needed medication.
Conclusions
Medication exposure prevalence varied by definition and medication. Using ≥ 1 filled prescriptions in the 1st trimester yielded prevalence estimates comparable to those from more complex definitions, supporting its use as a pragmatic standard. Sensitivity analyses and transparent reporting of exposure definition are essential to ensure replicability and critical appraisal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medications and Pregnancy Unit of the CHU Sainte-Justine Azrieli Research Center, Montréal, Québec, Canada.
- Faculty of Pharmacy, University of Montréal, Montréal, Québec, Canada.
- Department of Clinical Pharmacology, Pharmacy, and Environmental Medicine, University of Southern Denmark, Odense, Denmark.
- Research Unit OPEN, Department of Clinical Research, University of Southern Denmark and Odense University Hospital, Odense, Denmark.
ORCID-Profile: Gabra Nohmie, Anick Bérard, Anton Pottegård, Mette Bliddal
Zitieren
APA
Nohmie, G., Bérard, A., Pottegård, A., & Bliddal, M. (2026). Medication Exposure Definitions in Perinatal Pharmacoepidemiology: Implications for Pregnancy Studies. Paediatric and Perinatal Epidemiology. https://doi.org/10.1111/ppe.70158
Vancouver
Nohmie G, Bérard A, Pottegård A, Bliddal M. Medication Exposure Definitions in Perinatal Pharmacoepidemiology: Implications for Pregnancy Studies. Paediatric and Perinatal Epidemiology. 2026. doi:10.1111/ppe.70158
BibTeX
@article{Nohmie2026,
author = {Nohmie, Gabra and Bérard, Anick and Pottegård, Anton and Bliddal, Mette},
title = {Medication Exposure Definitions in Perinatal Pharmacoepidemiology: Implications for Pregnancy Studies},
journal = {Paediatric and Perinatal Epidemiology},
year = {2026},
doi = {10.1111/ppe.70158}
}
EUVIMED